Vitamin D receptor alleles and rates of bone loss: Influences of years since menopause and calcium intake
- 1 June 1995
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 10 (6) , 978-984
- https://doi.org/10.1002/jbmr.5650100620
Abstract
A genetic marker for the 1,25‐dihydroxyvitamin D receptor (VDR) is reported to account for much of the heritable component of bone density. It is not known whether VDR genotype influences bone accretion or loss, or how it is related to calcium metabolism. The VDR genotype was determined in 229 healthy postmenopausal women who previously participated in a calcium trial. VDR alleles were designated according to presence (b) or absence (B) of the BsmI restriction enzyme cutting site. There were 83 bb, 102 Bb, and 44 BB individuals. Two‐thirds of the women took 500 mg of calcium supplement (mean calcium intake = 892 mg/day) and one‐third a placebo (mean = 376 mg/day). Bone mineral density (BMD) at the femoral neck, spine, and radius were measured by dual‐ and single‐photon absorptiometry at baseline and after 1 and 2 years. Among women more than 10 years postmenopausal, those with the BB genotype had the lowest femoral neck BMD. Rates of bone loss over 2 years were greater in the BB group at all sites (e.g., at the femoral neck, bb, 0.45 ± 0.43; Bb, ‐0.01 ± 0.40; BB, ‐0.99 ± 0.50%/year; BB vs. bb, p = 0.01), and this trend was found both in women p = 0.02) and those ≥10 years (radius, bb, ‐0.71 ± 0.41; Bb, 0.08 ± 0.39; BB, ‐1.41 ± 0.49% per year; BB vs. Bb, p < 0.01). At the femoral neck, bone loss appeared to be modified by calcium intake (e.g., in the BB genotype: +0.03 ± 0.61 in supplemented vs. ‐2.01 ± 0.75%/year in placebo, in bb: 0.57 ± 0.58 vs. 0.32 ± 0.47%/year; interaction term p = 0.09), and this trend was also present in both early and late menopause. Rates of change at the radius and spine in BB were not significantly influenced by calcium at the intake levels of this study group. These results indicate that postmenopausal bone loss is influenced by the VDR genotype and suggest the adverse effect of the susceptible allele at the hip may be reduced by raising calcium intake.Keywords
Funding Information
- USDA Human Nutrition Research Center (53–3K06–5–10)
This publication has 24 references indexed in Scilit:
- Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus.Journal of Clinical Investigation, 1994
- Vitamin D receptor gene polymorphism and bone mineral density in healthy Japanese womenThe Lancet, 1994
- Heritable and life-style determinants of bone mineral densityJournal of Bone and Mineral Research, 1993
- Relation of fractional 47Ca retention to season and rates of bone loss in healthy postmenopausal womenJournal of Bone and Mineral Research, 1991
- Smoking and bone loss among postmenopausal womenJournal of Bone and Mineral Research, 1991
- Dietary calcium, physical activity, and risk of hip fracture: a prospective study.BMJ, 1989
- Reduced Bone Mass in Daughters of Women with OsteoporosisNew England Journal of Medicine, 1989
- DIETARY CALCIUM AND RISK OF HIP FRACTURE: 14-YEAR PROSPECTIVE POPULATION STUDYThe Lancet, 1988
- Intestinal Calcium Absorption and Serum Vitamin D Metabolites in Normal Subjects and Osteoporotic PatientsJournal of Clinical Investigation, 1979
- Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.Journal of Clinical Investigation, 1976